These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [ Zhang B; Fraser BH; Klenner MA; Chen Z; Liang SH; Massi M; Robinson AJ; Pascali G Chemistry; 2019 Jun; 25(32):7613-7617. PubMed ID: 30977166 [TBL] [Abstract][Full Text] [Related]
9. On-chip pre-concentration and complexation of [¹⁸F]fluoride ions via regenerable anion exchange particles for radiochemical synthesis of Positron Emission Tomography tracers. De Leonardis F; Pascali G; Salvadori PA; Watts P; Pamme N J Chromatogr A; 2011 Jul; 1218(29):4714-9. PubMed ID: 21683956 [TBL] [Abstract][Full Text] [Related]
10. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096 [TBL] [Abstract][Full Text] [Related]
11. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641 [TBL] [Abstract][Full Text] [Related]
12. [(18)F]-Organotrifluoroborates as Radioprosthetic Groups for PET Imaging: From Design Principles to Preclinical Applications. Perrin DM Acc Chem Res; 2016 Jul; 49(7):1333-43. PubMed ID: 27054808 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide. Kuhnast B; de Bruin B; Hinnen F; Tavitian B; Dollé F Bioconjug Chem; 2004; 15(3):617-27. PubMed ID: 15149190 [TBL] [Abstract][Full Text] [Related]
14. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics. Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and 18F-labeling of the analogues of Omecamtiv Mecarbil as a potential cardiac myosin imaging agent with PET. Zhang M; Mou T; Zhao Z; Peng C; Ma Y; Fang W; Zhang X Nucl Med Biol; 2013 Jul; 40(5):689-96. PubMed ID: 23566883 [TBL] [Abstract][Full Text] [Related]
16. Automated synthesis and purification of [18F]fluoro-[di-deutero]methyl tosylate. Beyerlein F; Piel M; Höhnemann S; Rösch F J Labelled Comp Radiopharm; 2013 Jun; 56(7):360-3. PubMed ID: 24285440 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide. Hausner SH; Bauer N; Sutcliffe JL Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053 [TBL] [Abstract][Full Text] [Related]
18. On the preparation of fluorine-18 labelled XeF(2) and chemical exchange between fluoride ion and XeF(2). Vasdev N; Pointner BE; Chirakal R; Schrobilgen GJ J Am Chem Soc; 2002 Oct; 124(43):12863-8. PubMed ID: 12392433 [TBL] [Abstract][Full Text] [Related]